Madrigal's Rezdiffra will have the NASH market all to itself -- at least for a while.
Humana (HUM) expects 2023 net membership gains to be a minimum of 10.9% from the 2022 projection.
Divesting operations like PANTHERx, Magellan Specialty Health and others are going to enable Centene (CNC) to intensify its focus on its core Managed Care business.
UnitedHealth (UNH) expects the top line to be within the range of $357-$360 billion in 2023.
Cigna (CI) expects its long-term adjusted earnings per share to witness 10-13% average annual growth.
The improvement of the economy is likely to support UnitedHealth's (UNH) commercial business recovery.
Of the 50 million visits to Teladoc (TDOC), around one-third took place in the last year alone.
Select Medical (SEM) reports improved performance in the Rehabilitation Hospital unit for the third quarter.
Encompass Health (EHC) intends to open 6-10 de novo locations and increase the bed count by 100-150 per annum, till 2026.
Teladoc (TDOC) projects total visits in the band of 18.4-18.6 million for 2022.